Latest news with #pancreaticenzymes
Medscape
27-06-2025
- Health
- Medscape
Food Allergies Less Common in Children With Cystic Fibrosis
TOPLINE: In the US, children with cystic fibrosis (CF) were significantly less likely to develop food allergies than children without CF. However, boys and children not receiving pancreatic enzyme replacement therapy had disproportionately higher rates of food allergy. Determination of food allergy is important in CF because nonspecific gastrointestinal symptoms associated with CF may be misdiagnosed as food allergy. METHODOLOGY: Researchers conducted a retrospective study to observe the prevalence, associated factors, and phenotypes of food allergies in children with CF. They included 289 children with CF (mean age, 11.93 years; 51.21% boys) who had at least one clinical encounter between August 2021 and August 2022 at two academic institutions in St. Louis. The prevalence of food allergy in children with CF was compared with that in a nationally representative 2018 sample of children without the condition. TAKEAWAY: The prevalence of food allergy in children with CF was 3.81% (95% CI, 1.91%-6.71%), significantly lower than the 7.60% (95% CI, 7.10%-8.10%; P = .015) reported in children without CF. Compared with boys with CF (6.08%), girls with CF had a significantly lower prevalence of being diagnosed with food allergy (1.42%; P = .038). Children who did not receive pancreatic enzyme replacement therapy had a higher prevalence of food allergy than those who received it (9.09% vs 2.25%; P = .020). IN PRACTICE: 'These results highlight the importance of thorough investigation into FA [food allergy] labels in patients with CF, particularly as this population may benefit from the incorporation of high-protein, high-fat allergens in the diet,' the study authors wrote. SOURCE: Stephanie Leeds, MD, with the Yale University School of Medicine, New Haven, Connecticut, was the corresponding author of the study, which was published online on June 21 in the Annals of Allergy, Asthma & Immunology. LIMITATIONS: This study was limited by its retrospective design, a small number of food allergy cases, the use of criteria to confirm food allergies that differed from those in a prior study, and potential gaps in electronic medical records. DISCLOSURES: Some authors reported providing consultation services to or receiving funding or scholarships from various pharmaceutical companies or organizations. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Yahoo
07-06-2025
- Health
- Yahoo
Cancer patients facing digestion drug shortage
Pharmacists in the Channel Islands have confirmed they are dealing with an ongoing shortage of a drug used by cancer patients. It follows a shortage of Creon, a pancreatic enzyme replacement therapy (Pert), being described by pharmacists in the UK as "one of the worst" examples of a medicine shortage. The drug does not treat cancer but is used by patients with pancreatic cancer, cystic fibrosis and chronic pancreatitis to help with digestion. A spokesperson from the Guernsey Prescribing Support Unit said there have been ongoing supply issues with Pert since summer 2024, with the department of health in England issuing a national patient safety alert in December 2024. The spokesperson said: "Local pharmacies have been working hard to help maintain supplies of medication for patients and at times this has proved difficult." They said there were an average of 70 Pert prescriptions dispensed each month in Guernsey, but they haven't received any reports of patients going without the drug. This was testament to the efforts of community pharmacy teams, the spokesperson added. The acting director of Pharmacy Services in Jersey, Kevin Smith, said the shortage of these medicines was expected to continue for many months. He said Jersey has introduced measures to help manage local supplies, such as issuing shorter prescription durations. Clinical and pharmacy teams were working with the hospital to find suitable alternative treatments where needed, he added. Jersey oncology consultant, Elizabet Gomes Dos Santos, said: "Patient safety remains our highest priority. "We are committed to maintaining the highest standards of care and ensuring that all patients continue to receive the support they need during this period of constrained supply." Follow BBC Guernsey on X and Facebook. Follow BBC Jersey on X and Facebook. Send your story ideas to Islanders reminded to pay prescription charges Cancer charity fears lack of drug could cost lives Cancer patients get quicker access to medication
Yahoo
07-06-2025
- Health
- Yahoo
Cancer patients facing digestion drug shortage
Pharmacists in the Channel Islands have confirmed they are dealing with an ongoing shortage of a drug used by cancer patients. It follows a shortage of Creon, a pancreatic enzyme replacement therapy (Pert), being described by pharmacists in the UK as "one of the worst" examples of a medicine shortage. The drug does not treat cancer but is used by patients with pancreatic cancer, cystic fibrosis and chronic pancreatitis to help with digestion. A spokesperson from the Guernsey Prescribing Support Unit said there have been ongoing supply issues with Pert since summer 2024, with the department of health in England issuing a national patient safety alert in December 2024. The spokesperson said: "Local pharmacies have been working hard to help maintain supplies of medication for patients and at times this has proved difficult." They said there were an average of 70 Pert prescriptions dispensed each month in Guernsey, but they haven't received any reports of patients going without the drug. This was testament to the efforts of community pharmacy teams, the spokesperson added. The acting director of Pharmacy Services in Jersey, Kevin Smith, said the shortage of these medicines was expected to continue for many months. He said Jersey has introduced measures to help manage local supplies, such as issuing shorter prescription durations. Clinical and pharmacy teams were working with the hospital to find suitable alternative treatments where needed, he added. Jersey oncology consultant, Elizabet Gomes Dos Santos, said: "Patient safety remains our highest priority. "We are committed to maintaining the highest standards of care and ensuring that all patients continue to receive the support they need during this period of constrained supply." Follow BBC Guernsey on X and Facebook. Follow BBC Jersey on X and Facebook. Send your story ideas to Islanders reminded to pay prescription charges Cancer charity fears lack of drug could cost lives Cancer patients get quicker access to medication
BBC News
07-06-2025
- Health
- BBC News
Channel Island pharmacists confirm digestion drug shortage
Pharmacists in the Channel Islands have confirmed they are dealing with an ongoing shortage of a drug used by cancer follows a shortage of Creon, a pancreatic enzyme replacement therapy (Pert), being described by pharmacists in the UK as "one of the worst" examples of a medicine drug does not treat cancer but is used by patients with pancreatic cancer, cystic fibrosis and chronic pancreatitis to help with digestion.A spokesperson from the Guernsey Prescribing Support Unit said there have been ongoing supply issues with Pert since summer 2024, with the department of health in England issuing a national patient safety alert in December 2024. The spokesperson said: "Local pharmacies have been working hard to help maintain supplies of medication for patients and at times this has proved difficult."They said there were an average of 70 Pert prescriptions dispensed each month in Guernsey, but they haven't received any reports of patients going without the was testament to the efforts of community pharmacy teams, the spokesperson added. The acting director of Pharmacy Services in Jersey, Kevin Smith, said the shortage of these medicines was expected to continue for many said Jersey has introduced measures to help manage local supplies, such as issuing shorter prescription and pharmacy teams were working with the hospital to find suitable alternative treatments where needed, he added. Jersey oncology consultant, Elizabet Gomes Dos Santos, said: "Patient safety remains our highest priority. "We are committed to maintaining the highest standards of care and ensuring that all patients continue to receive the support they need during this period of constrained supply."
